Previous research has shown that circulating CTRP3 levels are reduced with conditions associated with cardiovascular events such as obesity and metabolic syndrome (Ban et al., 2014; Deng et al., 2015; Qu et al., 2015; Wolf et al., 2015). This evidence concerns the gene C1QTNF3 and obesity disorder.